NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.) To Present At The Maxim Group Annual Growth Conference

EMERYVILLE, Calif.--(BUSINESS WIRE)--Dr. Ron Najafi, CEO of NovaBay Pharmaceuticals, Inc. (AMEX: NBY & TSX: NBY, http://www.novabaypharma.com), a clinical stage company developing non-antibiotic anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral and fungal infections, will present at the Maxim Group Growth Conference. The conference will be held at the Grand Hyatt New York Hotel in New York City on Tuesday, October 7, 2008. NovaBay’s presentation is scheduled to begin at 1:30 PM EDT.